title: βig-h3 regulates store-operated Ca2+ entry and promotes the invasion of human hepatocellular carcinoma cells.
abstract: βig-h3 is a TGF-β (transforming growth factor β)-induced ECM (extracellular matrix) protein that induces the secretion of MMPs (matrix metalloproteinases). However, the mechanism of induction is yet to be established. In this study, siRNAs (small interfering RNAs) targeted against βig-h3 were transfected into SMMC-7721 cells [a HCC (human hepatocellular carcinoma) cell line] to knockdown the expression of βig-h3. We found that NiCl2, a potent blocker of extracellular Ca2+ entry, reduced βig-h3-induced secretion of MMP-2 and -9. Further investigation suggested that reduction in the levels of βig-h3 decreased the secretion of MMP-2 and -9 that was enhanced by an increase in the concentration of extracellular Ca2+. SNAP (S-nitroso-N-acetylpenicillamine), a NO (nitric oxide) donor, and 8-Br-cGMP (8-bromo-cGMP) inhibited thapsigargin-induced Ca2+ entry and MMP secretion in the invasive potential of human SMMC-7721 cells. Further, the inhibitory effects of 8-Br-cGMP and SNAP could be significantly enhanced by down-regulating βig-h3. βig-h3 attenuates the negative regulation of NO/cGMP-sensitive store-operated Ca2+ entry. Our findings suggest that the expression of βig-h3 might play an important role in the regulation of store-operated Ca2+ entry to increase the invasive potential of HCC cells.
authors.affiliation: Cell Engineering Research Centre and Department of Cell Biology, State Key Laboratory of Cancer Biology, State Key Discipline of Cell Biology, Fourth Military Medical University, Xian 710032, Peoples Republic of China.
authors.forename: Yun-Shan
authors.initials: YS
authors.lastname: Guo
authors.forename: Juan
authors.initials: J
authors.lastname: Tang
authors.forename: Bo
authors.initials: B
authors.lastname: Chen
authors.forename: Wan
authors.initials: W
authors.lastname: Huang
authors.forename: Yong
authors.initials: Y
authors.lastname: Li
authors.forename: Hong-Yong
authors.initials: HY
authors.lastname: Cui
authors.forename: Xin
authors.initials: X
authors.lastname: Zhang
authors.forename: Shi-Jie
authors.initials: SJ
authors.lastname: Wang
authors.forename: Zhi-Nan
authors.initials: ZN
authors.lastname: Chen
authors.forename: Jian-Li
authors.initials: JL
authors.lastname: Jiang
mesh_terms: D002118:Calcium / Q000378:metabolism*; D006528:Carcinoma, Hepatocellular / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D045744:Cell Line, Tumor; D006152:Cyclic GMP / Q000031:analogs & derivatives / Q000494:pharmacology; D016326:Extracellular Matrix Proteins / Q000235:genetics* / Q000378:metabolism*; D005455:Fluorescent Antibody Technique; D006801:Humans; D008113:Liver Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D009361:Neoplasm Invasiveness; D009532:Nickel / Q000494:pharmacology; D034622:RNA Interference; D034741:RNA, Small Interfering; D020133:Reverse Transcriptase Polymerase Chain Reaction; D026423:S-Nitroso-N-Acetylpenicillamine / Q000378:metabolism; D019284:Thapsigargin / Q000494:pharmacology; D014162:Transfection; D016212:Transforming Growth Factor beta / Q000235:genetics* / Q000378:metabolism*; D000099222:betaIG-H3 Protein
chemical_list: D002118:Calcium; D006152:Cyclic GMP; D016326:Extracellular Matrix Proteins; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9; D009532:Nickel; D034741:RNA, Small Interfering; D026423:S-Nitroso-N-Acetylpenicillamine; D019284:Thapsigargin; D016212:Transforming Growth Factor beta; D000099222:betaIG-H3 Protein; C016276:8-bromocyclic GMP; C022838:nickel chloride